Ara
Toplam kayıt 1, listelenen: 1-1
PDB100 - Cost-Effectiveness of Exenatide Twice Daily (Bid) Added To Basal Insulin Compared To A Bolus Insulin Add-On In Turkey
(Elsevier Science Inc, 2014)
Objectives
Type 2 diabetes (T2D) patients on basal insulin with uncontrolled HbA1c levels often receive an add-on with bolus insulin to lower HbA1c levels. The aim of this analysis is to estimate long-term cost-effectiveness ...